Maximon Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-07-2024
- Paid Up Capital ₹ 0.10 M
as on 29-07-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -32.14%
(FY 2023)
- Profit -1028.90%
(FY 2023)
- Ebitda -6222812.50%
(FY 2023)
- Net Worth -413.50%
(FY 2023)
- Total Assets -20.63%
(FY 2023)
About Maximon Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Hegde, Harshavardhan Hegde, Rakesh Mattoo, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900DL2018PTC335210
- Company No.
335210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maximon Pharma Private Limited offer?
Maximon Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Common Disease Medicines, Pharmaceutical Capsules, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Ayurvedic & Herbal Extracts.
Who are the key members and board of directors at Maximon Pharma?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshavardhan Hegde  | Director | 12-Jun-2018 | Current |
| Anjali Hegde | Director | 01-Aug-2021 | Current |
| Rakesh Mattoo | Director | 12-Jun-2018 | Current |
| Akshay Saxena | Director | 12-Jun-2018 | Current |
| Sarita Kapur | Director | 01-Aug-2021 | Current |
| Arundhati Hegde | Director | 01-Aug-2021 | Current |
Financial Performance of Maximon Pharma.
Maximon Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.14% decrease. The company also saw a substantial fall in profitability, with a 1028.9% decrease in profit. The company's net worth observed a substantial decline by a decrease of 413.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maximon Pharma?
In 2023, Maximon Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nutralodge Private LimitedActive 3 years 6 monthsHarshavardhan Hegde, Rakesh Mattoo and 1 more are mutual person
Team Ortho Private LimitedActive 11 years 7 monthsAnjali Hegde and Harshavardhan Hegde are mutual person
- Virgil Healthcare Platforms Private LimitedActive 1 year 8 months
Harshavardhan Hegde is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maximon Pharma?
Maximon Pharma has a workforce of 8 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maximon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maximon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
